[1] ZHAO BJ.Analysis on the use of psychotropic drugs in a hospital from 2013 to 2016[J]. Guide of China Medicine(中国医药指南), 2018, 16(3): 26. [2] 《National mental health work plan (2015-2020)》unscramble-Deputy director of national health and Family Planning Commission、Director of the State Administration of traditional Chinese Medicine Wang GuoQiang[J]. Public Health in the capital, 2016, 10(01): 43-46. [3] BALLON J, STROUP TS.Polypharmacy for schizophrenia[J].Curr Opin Psychiat, 2013, 26(2): 208-213. [4] LIEBERMAN JA, STROUP TS, MCEVOY JP, et al.Effectiveness of antipsychotic drugs in patients with chronic schizophrenia[J]. N Engl J Med, 2005, 353(12): 1209-1223. [5] Ministry of Health of the People's Republic of China. Provisions for Adverse Drug Reaction Reporting and Monitoring (Order No.81 of the Ministry of Health) [EB/OL].[2011-05-04]. http://www.gov.cn/flfg/2011-05/24/content_1870110.htm. [6] ZHANG DL, LU L, YAO P, et al.Analysis of 183 cases of adverse drug reactions induced by atypical antipsychotropic drugs[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(2): 109-112. [7] HE MQ, WU SL, XIAO JP, et al.Analysis of adverse drug reactions caused by antipsychotic drugs in the inpatients in our hospital[J]. Chin Hosp Pharm J(中国医院药学杂志), 2019, 39(18): 1888-1892. [8] XIAO YL, WANG HG, GAO ZS, et al.Analysis of adverse drug reactions of antipsychotic drugs in 213 cases[J]. Chin Hosp Pharm J(中国医院药学杂志), 2016, 36(11): 930-932. [9] ZHAO JP.Guidelines for the prevention and treatment of schizophrenia 2nd Edition(精神分裂症防治指南第二版)[M]. China Medical Electronic Audio Visual Press, 2015. [10] MA Y, SHEN JW, ZHANG JM, et al.Analysis of adverse drug reaction induced by psychotic drugs[J]. China Pharmacy(中国药房), 2011, 22 (10): 921-923. [11] SONG HX.Analysis on adverse drug reaction reports of psychiatric hospital inpatients in our hospital[J]. Chines Journal of Drug Evaluation(中国药物评价), 2016, 33(3): 168-171. [12] CHERYL CL, ROMAYNE G, CHUKWUMA UN, et al.Clinical course, neurobiology and therapeutic approaches to treatment resistant schizophrenia. toward an integrated view[J]. Frontiers in Psychiatry, 2019(10): 601-608. [13] ZHANG JJ, LI X, ZHANG YH, et al.Analysis of antipsychotic drugs in the treatment of schizophrenia[J]. Contemporary Medical Symposium(当代医药论丛), 2019, 17(4): 113-114. [14] GUO F, LI T, SUN RJ, et al.Effects of clinical pharmacists intervention on the use of psychotropic drugs of category ii in a psychiatric hospital[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(9): 550-560. |